Background. Anaplastic thyroid cancer (ATC) responds poorly to conventional therapies and
requires a multidisciplinary approach to manage. The aim of the current study is to explore …

Background Anaplastic thyroid cancer (ATC) is a highly aggressive malignancy with dismal
prognosis. This study aimed to identify the independent risk factors and construct a readily-to …

Anaplastic thyroid carcinoma (ATC) accounts for only 1 to 2% of all thyroid carcinomas, but it
is one of the most lethal neoplasms in humans. To obtain further insights into this” orphan …

We investigated integrin-linked kinase (ILK), a focal adhesion serine-threonine protein
kinase, as a new molecular target for treating anaplastic thyroid cancer. ILK mediates cell …

Thyroid cancer is the most common endocrine malignancy accounting for nearly 95% of
endocrine cancers according to the American Cancer Society. In 2009, more than 37,000 …

Background/Aim: Anaplastic thyroid cancer (ATC) is one of the most aggressive human
malignancies, remaining generally incurable. Histone deacetylase (HDAC) seems to play a …

Anaplastic thyroid carcinoma (ATC) is one of the most lethal malignancies; poorly
differentiated thyroid carcinoma (PDTC) is a new diagnosis for rare aggressive thyroid …

Purpose Anaplastic thyroid cancer (ATC) is a rare tumor with a lethal clinical course despite
aggressive multimodal therapy. Intensity-modulated radiotherapy (IMRT) may achieve a …

Purpose Anaplastic thyroid carcinoma (ATC) is an orphan disease with a fatal outcome.
Surgery to the primary tumor in metastatic ATC is controversial. Determination of specific …

Background Controversies regarding anaplastic thyroid cancer (ATC) surround
aggressiveness of tumor resection in the presence of extrathyroidal extension and the …